Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Bienaime Jean Jacques
Relationship:   Director
City:   Palo Alto
State:   CA
   
Insider Summary:
  
   
Companies Owned :   7    
Direct Shares   537,854    

Indirect Shares

   247,533      
Direct Value   $43,021,652    

Indirect Value

   $21,938,850      
Total Shares   785,387      
Total Value   $64,960,502      


Biomarin Pharmaceutical Inc $41,992,185 Neurogesx Inc $0 Portola Pharmaceuticals Inc $12,729 Immunic Inc $23,495 Incyte Corp $889,298 Immunome Inc. $103,945 Biomarin Pharmaceutical Inc $41,992,185 Neurogesx Inc $0 Portola Pharmaceuticals Inc $12,729 Immunic Inc $23,495 Incyte Corp $889,298 Immunome Inc. $103,945
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    1   
    1    

     Stock price went up :
    0   
    0    
     Stock price went down :
    1   
    1    
   
     Gain/Loss Ratio :
   -1.0   
   -1.0   
     Percentage Gain/Loss :
   -34.0%
 -5.5%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Biomarin Pharmaceutical Inc BMRN Director 2024-05-20 473,792 2024-05-20 247,533    Premium*  
            Neurogesx Inc NGSX Director 2011-07-26 21,748 0    Premium*  
            InterMune Inc ITMN Director 2014-09-29 0 2012-04-06 0    Premium*  
            Portola Pharmaceuticals Inc PTLA Director 2014-05-16 706 2013-05-28 0    Premium*  
            Immunic Inc IMUX Director 2018-09-24 18,500 2001-04-23 0    Premium*  
            Incyte Corp INCY Director 2023-06-14 15,493 0    Premium*  
            Immunome Inc. IMNM Director 2023-11-07 7,615 0    Premium*  
* Premium Members only  

Records found :    851         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 8 of 35
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2013-05-13 4 AS $68.12 $479,720 D/D (7,000) 88,101 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2013-05-13 4 AS $69.11 $552,896 I/I (8,000) 20,609 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2013-05-15 4 AS $68.55 $685,477 I/I (10,000) 20,609 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2013-05-16 4 AS $64.65 $129,307 I/I (2,000) 20,609 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2013-05-21 4 AS $64.14 $128,279 I/I (2,000) 30,609 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2013-09-16 4 AS $73.08 $146,163 I/I (2,000) 48,740 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2013-10-10 4 AS $66.76 $200,291 I/I (3,000) 45,740 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2013-10-16 4 AS $67.73 $135,450 I/I (2,000) 45,740 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2013-10-31 4 AS $62.72 $627,155 I/I (10,000) 45,740 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2013-11-05 4 AS $62.36 $311,779 I/I (5,000) 45,740 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2013-12-05 4 AS $69.70 $348,485 I/I (5,000) 50,740 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2013-12-24 4 AS $68.71 $687,143 I/I (10,000) 50,740 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2014-01-02 4 AS $68.90 $344,483 I/I (5,000) 50,740 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2014-01-06 4 AS $67.40 $674,096 I/I (10,000) 50,740 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2014-01-10 4 AS $70.00 $350,000 I/I (5,000) 50,740 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2014-02-20 4 AS $80.00 $640,000 I/I (8,000) 46,740 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2014-05-21 4 AS $56.19 $86,817 I/I (1,545) 47,195 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2014-05-22 4 AS $56.88 $56,876 I/I (1,000) 46,195 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2014-08-20 4 AS $70.00 $350,000 I/I (5,000) 46,195 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2014-10-21 4 AS $75.00 $150,000 I/I (2,000) 46,195 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2014-10-24 4 AS $80.00 $160,000 I/I (2,000) 46,195 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2014-11-25 4 AS $90.00 $180,000 I/I (2,000) 43,195 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2014-12-10 4 AS $95.00 $190,000 I/I (2,000) 43,195 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2014-12-24 4 AS $88.73 $177,462 D/D (2,000) 227,157 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2014-12-24 4 AS $88.73 $266,193 I/I (3,000) 43,195 0 -
  851  Records found
  1   2   3   4   5   6   7   8  9   10   11   12   13   14   15   16   17   18   19   20   21   22   23   24   25   26   27   28   29   30   31   32   33   34   35      
  Page 8 of 35  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us